over three-quarters, 76%, believe FDA's approval process is too slow- 60% believe FDA hinders their use of new therapies
- 73% believe FDA approval delays hurt patients
- 70% favor changing the law to give physicians access to unapproved therapies if they carry a warning about their unapproved status
- 80% favor having Vioxx available again
Such were the findings of the sixth in a series of medical specialist surveys conducted by Competitive Enterprise Institute (CEI), which have consistently found a high level of dissatisfaction with FDA's performance.
Source: Competitive Enterprise Institute
Comment Preview